Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Astellas Pharma Inc. (Astellas)7.66M89.92%
Vaxcyte, Inc. (Vaxcyte)656K7.70%
Ipsen Pharma SAS (Ipsen)166K1.95%
Tasly Biopharmaceuticals Co., Ltd. (Tasly)32K0.38%
Merck Sharp & Dohme Corporation (Merck)5K0.06%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States153.73M100.00%
